pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3135a |
Genomic Coordinates | chr3: 20137565 - 20137641 |
Description | Homo sapiens miR-3135a stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3135a | ||||||||||||||
Sequence | 10| UGCCUAGGCUGAGACUGCAGUG |31 | ||||||||||||||
Evidence | Experimental | ||||||||||||||
Experiments | Illumina | ||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||
SNPs in miRNA |
|
||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | KLF10 | ||||||||||||||||||||
Synonyms | EGR-alpha, EGRA, TIEG, TIEG1 | ||||||||||||||||||||
Description | Kruppel like factor 10 | ||||||||||||||||||||
Transcript | NM_001032282 | ||||||||||||||||||||
Other Transcripts | NM_005655 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on KLF10 | |||||||||||||||||||||
3'UTR of KLF10 (miRNA target sites are highlighted) |
>KLF10|NM_001032282|3'UTR 1 CAGACCGGAAAGTGAAGAGTCAGAACTAACTTTGGTCTCAGCGGGAGCCAGTGGTGATGTAAAAATGCTTCCACTGCAAG 81 TCTGTGGCCCCACAACGTGGGCTTAAAGCAGAAGCCCCACAGCCTGGCACGAAGGCCCCGCCTGGGTTAGGTGACTAAAA 161 GGGCTTCGGCCACAGGCAGGTCACAGAAAGGCAGGTTTCATTTCTTATCACATAAGAGAGATGAGAAAGCTTTTATTCCT 241 TTGAATATTTTTTGAAGGTTTCAGATGAGGTCAACACAGGTAGCACAGATTTTGAATCTGTGTGCATATTTGTTACTTTA 321 CTTTTGCTGTTTATACTTGAGACCAACTTTTCAATGTGATTCTTCTAAAGCACTGGTTTCAAGAATATGGAGGCTGGAAG 401 GAAATAAACATTACGGTACAGACATGGAGATGTAAAATGAGTTTGTATTATTACAAATATTGTCATCTTTTTCTAGAGTT 481 ATCTTCTTTATTATTCCTAGTCTTTCCAGTCAACATCGTGGATGTAGTGATTAAATATATCTAGAACTATCATTTTTACA 561 CTATTGTGAATATTTGGAATTGAACGACTGTATATTGCTAAGAGGGCCCAAAGAATTGGAATCCTCCTTAATTTAATTGC 641 TTTGAAGCATAGCTACAATTTGTTTTTGCATTTTTGTTTTGAAAGTTTAACAAATGACTGTATCTAGGCATTTCATTATG 721 CTTTGAACTTTAGTTTGCCTGCAGTTTCTTGTGTAGATTTGAAAATTGTATACCAATGTGTTTTCTGTAGACTCTAAGAT 801 ACACTGCACTTTGTTTAGAAAAAAAACTGAAGATGAAATATATATTGTAAAGAAGGGATATTAAGAATCTTAGATAACTT 881 CTTGAAAAAGATGGCTTATGTCATCAGTAAAGTACCTTTATGTTATGAGGATATAATGTGTGCTTTATTGAATTAGAAAA 961 TTAGTGACCATTATTCACAGGTGGACAAATGTTGATGTTGTCCTGTTAATTTATAGGCGTTTTTTGGGGATGTGGAGGTA 1041 GTTGGGTAGAAAAATTATTAGAACATTCACTTTTGTTAACAGTATTTCTCTTTTATTCTGTTATATAGTGGATGATATAC 1121 ACAGTGGCAAAACAAAAGTACATTGCTTAAAATATATAGTGAAAAATGTCACTATATCTTCCCATTTAACATTGTTTTTG 1201 TATATTGGGTGTAGATTTCTGACATCAAAACTTGGACCCTTGGAAAACAAAAGTTTTAATTAAAAAAAATCCTTGTGACT 1281 TACAATTTGCACAATATTTCTTTTGTTGTACTTTATATCTTGTTTACAATAAAGAATTCCCTTTGGTATATGGAAAAAAA 1361 AAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000285407.6 | 3UTR | UUUAACAAAUGACUGUAUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000285407.6 | 3UTR | AAAGUUUAACAAAUGACUGUAUCUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
39 hsa-miR-3135a Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT092740 | SETD5 | SET domain containing 5 | 2 | 4 | ||||||||
MIRT098840 | PCMT1 | protein-L-isoaspartate (D-aspartate) O-methyltransferase | 2 | 2 | ||||||||
MIRT462095 | TMEM214 | transmembrane protein 214 | 2 | 2 | ||||||||
MIRT467617 | SLC7A5 | solute carrier family 7 member 5 | 2 | 2 | ||||||||
MIRT471258 | PGM2L1 | phosphoglucomutase 2 like 1 | 2 | 2 | ||||||||
MIRT474676 | KLF10 | Kruppel like factor 10 | 2 | 4 | ||||||||
MIRT474882 | KCTD5 | potassium channel tetramerization domain containing 5 | 2 | 4 | ||||||||
MIRT495898 | DESI1 | desumoylating isopeptidase 1 | 2 | 2 | ||||||||
MIRT511377 | IKZF3 | IKAROS family zinc finger 3 | 2 | 2 | ||||||||
MIRT534180 | SLC8A1 | solute carrier family 8 member A1 | 2 | 2 | ||||||||
MIRT540056 | CEP104 | centrosomal protein 104 | 2 | 2 | ||||||||
MIRT540147 | GTF2B | general transcription factor IIB | 2 | 4 | ||||||||
MIRT540184 | GSTM4 | glutathione S-transferase mu 4 | 2 | 2 | ||||||||
MIRT540465 | ZNF71 | zinc finger protein 71 | 2 | 2 | ||||||||
MIRT540584 | ERCC1 | ERCC excision repair 1, endonuclease non-catalytic subunit | 2 | 4 | ||||||||
MIRT542390 | WDR12 | WD repeat domain 12 | 2 | 2 | ||||||||
MIRT542407 | SYNJ2BP | synaptojanin 2 binding protein | 2 | 2 | ||||||||
MIRT542657 | TAF11 | TATA-box binding protein associated factor 11 | 2 | 2 | ||||||||
MIRT544052 | C9orf64 | chromosome 9 open reading frame 64 | 2 | 2 | ||||||||
MIRT551350 | AGBL5 | ATP/GTP binding protein like 5 | 2 | 2 | ||||||||
MIRT556685 | KLHL28 | kelch like family member 28 | 2 | 2 | ||||||||
MIRT561678 | RAD54L2 | RAD54 like 2 | 2 | 2 | ||||||||
MIRT576721 | Wars | tryptophanyl-tRNA synthetase | 2 | 2 | ||||||||
MIRT610461 | SYNPO2L | synaptopodin 2 like | 2 | 4 | ||||||||
MIRT632361 | SRRD | SRR1 domain containing | 2 | 2 | ||||||||
MIRT636713 | ARSK | arylsulfatase family member K | 2 | 2 | ||||||||
MIRT637684 | PPM1D | protein phosphatase, Mg2+/Mn2+ dependent 1D | 2 | 2 | ||||||||
MIRT648531 | KIAA1143 | KIAA1143 | 2 | 2 | ||||||||
MIRT658732 | ELK1 | ELK1, ETS transcription factor | 2 | 2 | ||||||||
MIRT666554 | RNF115 | ring finger protein 115 | 2 | 2 | ||||||||
MIRT667689 | KNSTRN | kinetochore localized astrin/SPAG5 binding protein | 2 | 2 | ||||||||
MIRT668169 | GDE1 | glycerophosphodiester phosphodiesterase 1 | 2 | 2 | ||||||||
MIRT668634 | DYRK1A | dual specificity tyrosine phosphorylation regulated kinase 1A | 2 | 2 | ||||||||
MIRT668692 | DNAL1 | dynein axonemal light chain 1 | 2 | 2 | ||||||||
MIRT679412 | GMCL1 | germ cell-less, spermatogenesis associated 1 | 2 | 2 | ||||||||
MIRT692259 | SLC2A5 | solute carrier family 2 member 5 | 2 | 2 | ||||||||
MIRT693281 | GINM1 | glycoprotein integral membrane 1 | 2 | 2 | ||||||||
MIRT698158 | TNFRSF13C | TNF receptor superfamily member 13C | 2 | 2 | ||||||||
MIRT705567 | ARHGEF18 | Rho/Rac guanine nucleotide exchange factor 18 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|